AstraZeneca FluMist Supply Jumps With CDC's Seal Of Approval
Executive Summary
US FDA's approval kept very limited amounts available the past two flu seasons; 2.7 million doses to be shipped for the 2018-2019 season.
You may also be interested in...
Next-Gen COVID Vaccines Could Be Awesome – If They Ever Get Made
Mucosal and other new vaccines in development should target infection and transmission prevention, as White House’s Ashish Jha calls for them to be ‘better than terrific.’ But with the market transitioning to a flu-like status, incentives for big investments seem limited.
FluMist Rejuvenated With CDC Advisory Panel Endorsement; Effectiveness Data Still To Come
US panel votes 12 to 2 to recommend use of nasal vaccine, which has been reformulated to include a new influenza A strain.
FDA Supports FluMist Use, Releases Lots For 2016 Flu Season
Despite a CDC advisory committee recommendation that FluMist not be used in the forthcoming influenza season, FDA says the benefits of the nasal formulation outweigh any potential risks.